articles

all the news

Results for the 3rd quarter 2018

- RESULTS OF THE CALL FOR EUROPEAN PROJECTS FET-OPEN - A NEW RESEARCH PROJECT WITH THE UNIVERSITY OF MONTPELLIERWe have received the answer from the European Commission: unfortunately, it is negative. However, we get a very good grade, and the comments of the...

read more
Proof of efficacy for dummies

Proof of efficacy for dummies

This article is for curious but unscientific readers. Expert readers will find a description of the planned protocol within the NanoStress consortium here. For 2 years, we have announced everywhere that to obtain our Proof of Efficacy will mark the...

read more
A joint experiment between CC&C and the IBDM

A joint experiment between CC&C and the IBDM

- Mechanical Signals and Cancer: a new experiment on colon cancer. First results expected early 2019. Based in Marseille, the IBDM brings together about twenty research teams that explore the field of developmental biology and associated pathologies, with daily...

read more
Results for the second quarter 2018

Results for the second quarter 2018

- EUROPEAN GRANT APPLICATION FET OPEN: 1.8 MILLION EURO REQUESTED, RESPONSE ON OCTOBER 16TH, 2018 - AFTER STANFORD UNIVERSITY, NEW PARTNERSHIPS IN PERSPECTIVE On May 16th, we submitted an application for a grant of 1.8 million Euro from the European Commission as part...

read more
20 months of extra life for pancreatic cancer patients

20 months of extra life for pancreatic cancer patients

In Chicago, on June 4th, was held the annual conference of the American Society of Clinical Oncology (ASCO), during which an interesting communication was made. The news comes from France, more precisely from Nancy. Already three years ago, the team of the Cancer...

read more
NanoStress: we answered the FET-Open call for projects

NanoStress: we answered the FET-Open call for projects

The FET-Open call of the European Commission finances disruptive innovation research projects capable of « changing the world ». We did not need it any less, so we submitted today a nomination file within the NanoStress consortium, in order to obtain the Proof of...

read more
Results for the first quarter 2018

Results for the first quarter 2018

- WITH THE SUPPORT OF INSERM, GET EUROPEAN FUNDS - LAST FUNDRAISE BEFORE CHANGING OUR FUNDING MODEL     The FET-Open call for projects, which is part of the Horizon 2020 program for research initiated by the European Commission, selects its laureates for...

read more
In vivo: Proof of Efficacy

In vivo: Proof of Efficacy

The principles The possibility of therapeutic use, of course, opens up enormous opportunities. The method fits into the current conception of carcinogenesis: impossibility of thinking the cancerous transformation without integrating the interaction Extra Cellular...

read more
Cancer a Genetic or Mechanical Disease?

Cancer a Genetic or Mechanical Disease?

"Mechanical signals play a vital role in cancer .... " This is a phrase that appears at the beginning of thousands of scientific articles, and more and more since 2005 date of the first article showing their importance in oncology (M Paszek, 2005). But for 60 years it...

read more
About our trip to San Francisco

About our trip to San Francisco

CC & C was honored to be one of the 3 high-tech start-ups selected in the 2017 NETVA program. As a reminder, NETVA, for New Technology Venture Accelarator, is a program sponsored by the French Embassy in Washington to develop scientific and industrial exchanges...

read more
More than 2.900 readers of our article !

More than 2.900 readers of our article !

It is a more than respectable score for a prose, it must be admitted, rather arid. Especially as the number of readers continues to increase steadily, while it was published more than a year ago. One more sign that physical oncology is gradually making its way into...

read more
Our executive summary 2018

Our executive summary 2018

Our Executive Summary is updated. This version becomes our reference document for the year 2018. Do not hesitate to download it : Executive Summary anglais -...

read more
Imaging the Force of Cancer: A European H2020 Program

Imaging the Force of Cancer: A European H2020 Program

The existence of this program is great news for anyone who believes in the future of applying the laws of physics and the use of mechanical signals in oncology. Europe supports a consortium of 16 participants that aims to image and to measure the active forces in a...

read more
After the failure of targeted therapies, what to propose?

After the failure of targeted therapies, what to propose?

About the article "Targeted therapies against cancer fall short of the hopes raised" by Professor Ian Tannock of the University of Toronto, Canada.   In this article, originally published in the prestigious New England Journal of Medicine, and then in Le Monde,...

read more
Status of our research

Status of our research

Plans of animal demonstrator completed   Thanks to Christian Chillet, of the G2ELab, our partner on superconducting magnets, our working hypotheses on the feasibility of the experimental device of the Proof of Efficiency are validated. Mr. Chillet gave us the...

read more

CELL CONTRAINT & CANCER
le Mas l’Hermite
331 chemin de la Poterie
f13280 Raphèle les Arles

articles

all the news

Results for the 3rd quarter 2018

- RESULTS OF THE CALL FOR EUROPEAN PROJECTS FET-OPEN - A NEW RESEARCH PROJECT WITH THE UNIVERSITY OF MONTPELLIERWe have received the answer from the European Commission: unfortunately, it is negative. However, we get a very good grade, and the comments of the...

read more

Proof of efficacy for dummies

This article is for curious but unscientific readers. Expert readers will find a description of the planned protocol within the NanoStress consortium here. For 2 years, we have announced everywhere that to obtain our Proof of Efficacy will mark the...

read more

A joint experiment between CC&C and the IBDM

- Mechanical Signals and Cancer: a new experiment on colon cancer. First results expected early 2019. Based in Marseille, the IBDM brings together about twenty research teams that explore the field of developmental biology and associated pathologies, with daily...

read more

Results for the second quarter 2018

- EUROPEAN GRANT APPLICATION FET OPEN: 1.8 MILLION EURO REQUESTED, RESPONSE ON OCTOBER 16TH, 2018 - AFTER STANFORD UNIVERSITY, NEW PARTNERSHIPS IN PERSPECTIVE On May 16th, we submitted an application for a grant of 1.8 million Euro from the European Commission as part...

read more

20 months of extra life for pancreatic cancer patients

In Chicago, on June 4th, was held the annual conference of the American Society of Clinical Oncology (ASCO), during which an interesting communication was made. The news comes from France, more precisely from Nancy. Already three years ago, the team of the Cancer...

read more

NanoStress: we answered the FET-Open call for projects

The FET-Open call of the European Commission finances disruptive innovation research projects capable of « changing the world ». We did not need it any less, so we submitted today a nomination file within the NanoStress consortium, in order to obtain the Proof of...

read more

Results for the first quarter 2018

- WITH THE SUPPORT OF INSERM, GET EUROPEAN FUNDS - LAST FUNDRAISE BEFORE CHANGING OUR FUNDING MODEL     The FET-Open call for projects, which is part of the Horizon 2020 program for research initiated by the European Commission, selects its laureates for...

read more

In vivo: Proof of Efficacy

The principles The possibility of therapeutic use, of course, opens up enormous opportunities. The method fits into the current conception of carcinogenesis: impossibility of thinking the cancerous transformation without integrating the interaction Extra Cellular...

read more

Cancer a Genetic or Mechanical Disease?

"Mechanical signals play a vital role in cancer .... " This is a phrase that appears at the beginning of thousands of scientific articles, and more and more since 2005 date of the first article showing their importance in oncology (M Paszek, 2005). But for 60 years it...

read more

About our trip to San Francisco

CC & C was honored to be one of the 3 high-tech start-ups selected in the 2017 NETVA program. As a reminder, NETVA, for New Technology Venture Accelarator, is a program sponsored by the French Embassy in Washington to develop scientific and industrial exchanges...

read more

More than 2.900 readers of our article !

It is a more than respectable score for a prose, it must be admitted, rather arid. Especially as the number of readers continues to increase steadily, while it was published more than a year ago. One more sign that physical oncology is gradually making its way into...

read more

Our executive summary 2018

Our Executive Summary is updated. This version becomes our reference document for the year 2018. Do not hesitate to download it : Executive Summary anglais -...

read more

Imaging the Force of Cancer: A European H2020 Program

The existence of this program is great news for anyone who believes in the future of applying the laws of physics and the use of mechanical signals in oncology. Europe supports a consortium of 16 participants that aims to image and to measure the active forces in a...

read more

After the failure of targeted therapies, what to propose?

About the article "Targeted therapies against cancer fall short of the hopes raised" by Professor Ian Tannock of the University of Toronto, Canada.   In this article, originally published in the prestigious New England Journal of Medicine, and then in Le Monde,...

read more

Status of our research

Plans of animal demonstrator completed   Thanks to Christian Chillet, of the G2ELab, our partner on superconducting magnets, our working hypotheses on the feasibility of the experimental device of the Proof of Efficiency are validated. Mr. Chillet gave us the...

read more

CELL CONTRAINT & CANCER
le Mas l’Hermite
331 chemin de la Poterie
f13280 Raphèle les Arles